Talent, expertise and location are key factors for investors
During the panel discussion that followed, and which was moderated by Patrik Frei, CEO of Venture Valuation, a distinguished panel of experts weighed in on European investment strategies and opportunities. The panel featured Reinhard Ambros, Head of Novartis Venture Fund, Vladimir Cmiljanovic, CEO of Piqur Therapeutics AG, and Mark Ginestro, Partner Healthcare Practice at KPMG.
The panel discussed why talent, expertise and location are the key factors to consider for investors like Novartis Venture Fund whether to invest in a company or not. Piqur Therapeutics recounted its early days as a spin-off from the University Basel, when it was difficult to find VC money. Instead, they found private investors in Basel. Not only was Basel discussed as an attractive location for financing, but also for its unique and diverse pool of experts: from oncology to immunology to regulatory experts, Basel has it all.